RCAN2 and metabolic dysfunction-associated steatotic liver disease: From these findings, we hypothesized that RCAN2 promotes the occurrence of NAFLD by affecting the storage of TG in the liver, but more studies are needed to verify this relationship and clarify the specific mechanism.